Disciplinary Committee decisions (24-26 August 2010)
The Disciplinary Committee of the Royal Pharmaceutical Society of Great Britain on 24-26 August 2010
The Disciplinary Committee of the Royal Pharmaceutical Society of Great Britain on 24-26 August 2010 and made the following directions:
1. On Tuesday 24 August 2010, following an application for restoration to the Register of Pharmacists on behalf of Jawid Ahmed Yusuf (previous registration number 84208), the committee directed that the application be refused.
2. On Wednesday 25 August 2010, the committee directed that, in accordance with article 52(4)(b) of the Pharmacists and Pharmacy Technicians Order 2007, the conditions imposed on Wenxi Tan (registration number 1081415) on 26 August 2009 (see below) should remain in force.
The committee further directed that the order be reviewed on 8 November 2010. On 26 August 2009, the committee imposed the following conditions on Miss Tan’s registration for a period of two years:
(i) not to work as a pharmacist, or in any position in the UK or elsewhere, for which registration with the Society is required;
(ii) if undertaking employment in a dispensary setting, to do so only at the level of a dispensing assistant under the direct supervision of a work place supervisor approved by the Society, who shall be a registered pharmacist;
(iii) to allow the Society to exchange information with, and receive progress reports, at least every three months from the approved work place supervisor;
(iv) to keep a handwritten logbook (separate to those maintained on practice premises) in which full details of any errors and/or near misses are recorded contemporaneously by her, such log to be countersigned by the work place supervisor on each occasion that an error and/or near miss is recorded;
(v) to undertake work involving the direct and/or indirect care of patients only with the prior agreement of her work place supervisor;
(vi)(a) to have regular meetings with her work place supervisor to review her work every week during the first eight weeks of her employment in any pharmacy, (b) thereafter to have regular meetings with her work place supervisor to review her work, the frequency of which should be determined by her workplace supervisor, but which shall not be more than four weeks apart;
(vii) to notify all employers (including the superintendent pharmacist or responsible pharmacist) or contractors or prospective employers (including the superintendent pharmacist or responsible pharmacist) or contractors, and agents acting on behalf of employers, whether for paid or voluntary pharmaceutical employment of the conditions in this order (in the case of prospective employers, this notification must be given at the time of application);
(viii) to arrange for her workplace supervisor to send a report on her progress and development directly to the fitness to practise directorate of the Society every three months for as long as these conditions remain in force;
(ix) before undertaking any employment in a pharmacy setting in the UK or elsewhere, to inform the Society’s fitness to practise directorate in writing of the arrangements Miss Tan has made for her work to be supervised and to provide the Society with the name and contact details of her work place supervisor;
(x) to comply with any re-education or retraining as required by the Society, including attendance at Centre for Pharmacy Postgraduate Education/NES Pharmacy/Welsh Centre for Pharmacy Professional Education, or return to practice courses approved by the Society;
(xi) to provide satisfactory evidence at any review hearing that she has completed up-to-date training in pharmacy practice, and that she is competent to provide such a service safely;
(xii) to provide satisfactory evidence at any review hearing in relation to any courses that she has undertaken, and in respect of her continuing professional development. Under article 56 of the Order, the committee’s direction of Wednesday 25 August 2010 is not to take effect until the expiration of a period of 28 days from the date on which the written notice of decision and the reasons for the decision was given or in a case where an appeal has been brought against the direction, until the appeal is determined or withdrawn.
3. On Thursday 26 August 2010, the committee directed that the interim order relating to the registration of Juliya Kondrasova (registration number 1084890) should remain in force. This order is subject to a review within six months if the principal hearing has not taken place.
On 3 March 2010, the committee made an order that Miss Kondrasova’s registration be suspended for a period of 18 months.
4. On Thursday 26 August 2010, the committee directed that the interim order relating to the registration of Michael James O’Sullivan (registration number 89994) should remain in force, in accordance with rule 39(2) of the Royal Pharmaceutical Society of Great Britain (Fitness to Practise and Disqualification etc. Rules) Order of Council 2007.
On 4 March 2010, the committee made an order that Mr O’Sullivan’s registration be suspended for a period of 18 months. The committee directed that the order take effect from Monday 8 March 2010.
Statutory Committees Secretariat
Citation: The Pharmaceutical Journal URI: 11023783
Recommended from Pharmaceutical Press